| Russ Middaugh, Ph.D. » |
Stability and Dynamics of Immunoglobulins |
Medimmune, Inc |
$249,693 |
12/1/2017 |
| Russ Middaugh, Ph.D. » |
The Development and Characterization of mRNA Lipid Nanoparticles (LNPs) |
Medimmune, Inc |
$251,086 |
12/1/2017 |
| Blake Peterson, Ph.D. » |
Synthetic Cell Surface Receptors that Control Signal Transduction |
G. Harold & Leila Y. Mathers Charitable Foundation |
$244,524 |
12/1/2017 |
| Berl Oakley, Ph.D. » |
Linking Regulation of Primary and Secondary Metabolism in Fungi for Improved Animal and Human Health |
Kansas State University |
$15,000 |
12/1/2017 |
| Wendy Picking, Ph.D. » |
Development of a combination vaccine targeting three major enteric pathogens |
Kansas City Area Life Sciences Institute |
$50,000 |
12/1/2017 |
| Mizuki Azuma, Ph.D. » |
O-GlcNAcylation of Ewing sarcoma proteins in chromosomal maintenance |
National Institutes of Health |
$165,125 |
12/5/2017 |
| Wendy Picking, Ph.D. » |
Development of a next generation vaccine to prevent pertussis |
National Institutes of Health |
$416,625 |
12/15/2017 |
| Laird Forrest, Ph.D. » |
Development of novel immunosuppressant prodrugs for treatment of ulcerative colitis |
PHRMA Foundation |
$40,000 |
1/1/2018 |
| William Picking, Ph.D. » |
Toward stabilization of Coccidioides delta cps1 as a canine vaccine against Valley Fever |
Anivive LifeSciences, Inc. |
$261,092 |
1/1/2018 |
| Brandon DeKosky, Ph.D. » |
New platforms for rapid and personalized TCR-based cancer immunotherapy |
University of Kansas Medical Center Research Institute |
$35,000 |
2/1/2018 |
| Frank Schoenen, Ph.D. » |
Exploiting ER stress pathway as a target of vulnerability in ovarian cancer |
University of New Mexico |
$29,026 |
3/1/2018 |
| Frank Schoenen, Ph.D. » |
Capitalizing on p53 loss/mutations in osteosarcoma by novel compounds |
KU Medical Center |
$101,372 |
4/1/2018 |
| Shi Fang Yan, Ph.D. » |
PINK1 signaling and synaptic mitochondria integrity in AD |
National Institutes of Health |
$416,625 |
4/1/2018 |
